A bipartisan group of senators led by Brian Schatz (D-Hawaii) has reintroduced the Marijuana Effective Studies Act of 2016 (MEDS Act), which will remove excessive regulatory barriers inhibiting researchers from obtaining marijuana plants to conduct studies assessing the drug’s medical effectiveness and safety.
Training Health Care Providers on Pain Management and Safe Use of Opioid Analgesics – Exploring the Path Forward
Persons interested in attending this public workshop must register online before May 1, 2017.
“We are committed to going through all of the important work HHS does — in payments, prescribing guidelines, and more — to ensure that we are not pushing doctors toward quick fixes that risk lives. Our goal, in all that we do, should be to promote healthy, evidence-based ways of managing pain and to help providers and patients make responsible choices.
In part, that will happen through the implementation of the National Pain Strategy, led by the Office of the Assistant Secretary for Health and the NIH, and through the Interagency Task Force on Pain Management, which is in the process of being assembled this spring,” Thomas E. Price, M.D.
CHICAGO, March 31, 2017 – The American Pain Society (APS), www.americanpainsociety.org, today condemned the Trump Administration’s proposed 19 percent cut in funding for the National Institutes of Health (NIH) and warned that such a draconian budget reduction would devastate biomedical research in the United States unless Congress acted to prevent it.
APS has a responsibility to our members and the scientific community to advocate against issues that can negatively impact the ability to conduct research and treat patients effectively.
Advocate for more support and increased pain research funding at NIH by submitting this fillable form to the US Senate.
The deadline is near! Urge the Obama Administration and the Department of Health & Human Services to ensure implementation and funding for the National Pain Strategy (NPS). Sign and share the petition by August 12! Sign the petition.
Up to $2 Million Pledged by Pfizer for Multiple Research Proposals
The American Pain Society (APS) today announced a new collaboration with Pfizer Independent Grants for Learning and Change (IGLC) to allocate up to $2 million to fund research grants focused on solutions to improve care for individuals with chronic pain.
APS and Pfizer Independent Grants for Learning and Change (IGLC) are excited to announce their collaboration in a new $2 million funding opportunity focused on improving care for individuals with chronic pain.
On Tuesday afternoon March 15th the CDC released the final version of their 2016 Guideline for Prescribing Opioids for Chronic Pain.
The American Pain Society (APS) today endorsed the federal government’s National Pain Strategy for its recommendations to better educate primary care physicians about pain and pain treatments, reduce stigma by increasing public awareness about pain and its overall impact on society, and expanding access to personalized multimodal and multidisciplinary pain care.
Pain Care Coalition – a national coalition for responsible pain care. Click here for the quarter two update from Bob Saner.
Help stop the unnecessary addition of new regulations for the use of animals in pain research.
APS is extremely pleased to advise you that the National Pain Strategy draft is now available for review. Individuals are encouraged to comment on the National Pain Strategy draft.
The APS “Pain Research Agenda for the 21st Century” is a goal-oriented approach emphasizing important outcomes that must be achieved to meaningfully advance pain treatment.
